Grifols (GIFLF) Deferred Taxes (2009 - 2014)
Grifols' (GIFLF) quarterly Deferred Taxes came in at $6.0 million in Q4 2014, down 70.68% on a YoY basis from $20.3 million in Q4 2013, and down 70.68% quarter-over-quarter from $20.3 million in Q4 2013.
Powered by 
Analysis
Grifols (GIFLF) Deferred Taxes (2009 - 2014) Analysis & Trends
Grifols (GIFLF) has reported Deferred Taxes for 6 consecutive years, with $6.0 million the latest figure, recorded in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -291.00 Mn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -587.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -69.70 Mn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 194.40 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -27.60 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 5.96 Mn |
| Dec 31, 2013 | 20.31 Mn |
| Dec 31, 2012 | 125.82 Mn |
| Dec 31, 2011 | -18.21 Mn |
| Dec 31, 2010 | 21.11 Mn |
| Dec 31, 2009 | 13.04 Mn |